Hospital supplies mean items used for therapeutic or diagnostic purposes essential for patient care, such as dressings, catheters, or syringes. The main types of hospital supplies are disposable hospital supplies, sterilization equipment, disinfectants, mobility aids, transportation equipment, and operating room equipment. Disposable hospital supplies are products that can be disposed of after single use and are intended to be used temporarily or only once. They are simple to operate and do not require maintenance and sterilization. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The end-users are hospitals and clinics, diagnostic laboratories, and others. The hospital supplies market research report is one of a series of new reports from The Business Research Company that provides hospital supplies market statistics, including hospital supplies industry global market size, regional shares, competitors with a hospital supplies market share, detailed hospital supplies market segments, market trends and opportunities, and any further data you may need to thrive in the hospital supplies industry. This hospital supplies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global hospital supplies market grew from $54.79 billion in 2022 to $58.71 billion in 2023 at a compound annual growth rate (CAGR) of 7.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The hospital supplies market is expected to grow to $74.2 billion in 2027 at a CAGR of 6.0%. The hospital supplies market is expected to benefit from the rise in precautionary measures being adopted to treat and control hospital-acquired infections (HAIs). HAIs, also known as nosocomial infections, are infections that patients contract during treatment for medical or surgical conditions. HAIs can occur in various healthcare facilities, including hospitals, surgical centres, and long-term care facilities such as nursing homes and rehabilitation facilities. According to WHO data, Of every 100 hospitalized patients at any given time, 7 in developed and 10 in developing countries will acquire at least one healthcare-associated infection. This is expected to boost the demand for hospital supplies and drive the market during the forecast period. The outbreak of COVID-19 disease (COVID-19) has acted as a restraint on the hospital supplies market in 2020 as supply chains were disrupted due to trade restrictions and healthcare organizations faced difficulties in acquiring new medical equipment. COVID-19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty in breathing. The virus was first identified in 2019 in Wuhan, Hubei province of the People’s Republic of China, and spread globally including Western Europe, North America, and Asia. Steps by national governments to contain the transmission have resulted in a decline in the manufacture and trade of medical equipment with countries entering a state of 'lock down' and the outbreak is expected to continue to have a negative impact on businesses throughout 2020 and into 2021. However, it is expected that the hospital supplies market will recover from the shock across the forecast period as it is a 'black swan' event and not related to ongoing or fundamental weaknesses in the market or the global economy. Injection manufacturers are increasingly investing in painless injections and needle-free technology as a replacement for conventional injections for faster delivery of drugs, hormone treatments, insulin, and vaccines. Painless injections include microneedle patches and laser-based devices to deliver drugs to a patient’s body. Microneedle patches are skin patches equipped with tiny plastic needles that dissolve within a short period and deliver vaccines painlessly in the form of a pressured stream of liquid. These devices are utilized to avoid pain and manage chronic illnesses such as diabetes. For instance, in November 2021, MyLife Technologies raised $4 million for further development of its needle-free drug delivery system. Major companies in the hospital supplies market include Becton Dickinson, B. Braun Group, Steris, Baxter International Inc., Stryker Corporation, Cardinal Health, Inc., Hill-Rom, Inc., Terumo Corporation, Medtronic Inc., and 3M Company. Asia-Pacific was the largest region in the global hospital supplies market in 2022. North America was the second largest region in the global hospital supplies market. The regions covered in the hospital supplies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the hospital supplies market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The hospital supplies market consists of sales of Hospital Stretchers, Patient Monitors, Sterilizers, and others that are used in hospitals. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global hospital supplies market is segmented - 1) By Type: Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables

Nephrology and urology devices are used in the diagnosis and treatment of kidney and genitourinary diseases. The main types of nephrology and urology devices are dialysis devices and equipment, urinary stone treatment devices and equipment, urinary incontinence and pelvic organ prolapse devices and equipment, benign prostatic hyperplasia (BPH) treatment devices and equipment, and endoscopy devices and equipment. Dialysis devices and equipment is a machines used in dialysis that filter a patient's blood to remove excess water and waste products when the kidneys are damaged, dysfunctional, or missing. The dialysis machine itself is an artificial kidney. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The various end-users are hospitals and clinics, diagnostic laboratories, and others. The nephrology and urology devices market research report is one of a series of new reports from The Business Research Company that provides nephrology and urology devices market statistics, including nephrology and urology devices industry global market size, regional shares, competitors with a nephrology and urology devices market share, detailed nephrology and urology devices market segments, market trends and opportunities, and any further data you may need to thrive in the nephrology and urology devices industry. This nephrology and urology devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global nephrology and urology devices market grew from $17.37 billion in 2022 to $18.63 billion in 2023 at a compound annual growth rate (CAGR) of 7.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The nephrology and urology devices market is expected to grow to $23.52 billion in 2027 at a CAGR of 6.0%. The increase in the patient pool due to the rising geriatric population globally contributed significantly to the growth of the nephrology and urology devices market during the historic period. According to the World Health Organization, the number of people aged 60 years and above was 1 billion in 2020 and the number will rise to 1.4 billion by 2030 and it will reach 2.1 billion by 2050. This rise in the geriatric population increased the demand for medical care and drove the healthcare expenditure. These factors increased the demand for these products and drove the market during the historic period. The nephrology and urology devices market was limited by the shortage of skilled workforce in most developed and developing countries, during the historic period. Equipment fabrication and integration require specialized skillsets relating to life sciences, pharmaceuticals, electronics, and software. These skillsets are available to a limited number of organizations, most of which are located in the USA and Europe. This shortage of skilled labour was a significant deterrent to the growth of the market during the historic period. The nephrology and urology market is witnessing a rise in new product launches. Due to the high competition in the market, many companies are investing in advanced technologies to widen product portfolios and increase their share in the market. For instance, in March 2020, Medi-Tate an Israel-based medical device company received authorization for iTind system that is used to implant and remove nitinol devices during bladder neck remodelling. Researchers at Washington University in St. Louis, the University of Illinois at Urbana-Champaign, and Northwestern University together developed a wireless implant to control overactive bladder using LED lights. Major companies in the nephrology and urology devices market include Baxter International Inc., Fresenius Medical Care AG & Co KGaA, Cook Group Incorporated, B. Braun Group, C. R. and Bard Inc. North America was the largest region in the global nephrology and urology devices market in 2022. Asia-Pacific was the second largest region in the global nephrology and urology devices market. The regions covered in the nephrology and urology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the nephrology and urology devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The nephrology and urology devices market consist of sales of instruments such as ureteral catheters, PCN catheters, urinary stents, stone baskets, urology guidewires, and renal dilators that are used to treat kidney and genitourinary diseases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global nephrology and urology devices market is segmented - 1) By Type: Dialysis Devices And Equipment, Urinary Stone Treatment Devices And Equipment, Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment, Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment, Endoscopy Devices And Equipment 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables

E-prescribing refers to a technological framework that allows physicians and other medical practitioners to write and send prescriptions to a participating pharmacy electronically instead of using handwritten or faxed notes or calling in prescriptions. The main types of components in e-prescribing are solutions and services. Services refer to the non-physical, intangible parts of our economy, as opposed to goods, which we can touch or handle. The deployment is web-based, cloud-based, and on-premise. The various end-users involved are hospitals, office-based physicians, and pharmaceuticals. The e-prescribing market research report is one of a series of new reports from The Business Research Company that provides e-prescribing market statistics, including e-prescribing industry global market size, regional shares, competitors with an e-prescribing market share, detailed e-prescribing market segments, market trends and opportunities, and any further data you may need to thrive in the e-prescribing industry. This e-prescribing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global e-prescribing market size grew from $1.67 billion in 2022 to $2.07 billion in 2023 at a compound annual growth rate (CAGR) of 24.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The e-prescribing market size is expected to grow to $4.92 billion in 2027 at a CAGR of 24.1%. The rising focus on reducing medical errors is expected to propel the growth of the e-prescribing market going forward. Medical error refers to an avoidable adverse effect of medical care on a patient. E-prescribing has significantly reduced errors resulting from undecipherable physician handwriting. For instance, in 2020, according to a Harvard study and a US-based educational research institute, 5.2 million medical errors occur in India annually. Furthermore, in 2020, according to a John Hopkins study, a US-based educational research institute, more than 250,000 people die in the US every year from medical errors, and it has been the third major cause of death after heart disease and cancer. Therefore, the rising focus on reducing medical errors is driving the growth of the e-prescribing market. The advent of technological transformation in healthcare is a key trend gaining popularity in the e-prescribing market. Major companies operating in the e-prescribing market are focused on developing new technological solutions to strengthen their position. For instance, in April 2022, Change Healthcare, a US-based healthcare technology company that includes e-prescribing, launched InterQual® 2022, the latest edition of the company’s flagship clinical decision support solution for the delivery of the latest and evidence-based appropriate care. This includes new criteria for emergent trends, restructured and interactive criteria to streamline workflows, and artificial intelligence (AI) to drive proactive insights and efficiency. All updates have been researched and independently peer-reviewed, so users will feel confident that the criteria are free of bias. In December 2021, Oracle, a US-based computer technology corporation, acquired Cerner for $28.3 billion. With this acquisition, Oracle plans to expand the company's global footprint as it invests heavily in healthcare. Cerner is a US-based health information technology company that includes e-prescribing. Major players in the e-prescribing market are Epic Systems Corporation, Allscripts Healthcare Solutions Inc., NextGen Healthcare Inc., Athenahealth, Relay Health, Henry Schein Inc., GE Healthcare, Computer Programs and Systems Inc., DrFirst.com Inc., Surescripts-RxHub, Medical Information Technology, Change Healthcare, Health Fusion Inc., eMDs Inc., and iMedX Inc. North America was the largest region in the e-prescribing market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the e-prescribing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the e-prescribing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The e-prescribing market consists of sales of softwares and services related to software. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global E prescribing market is segmented - 1) By Component: Solutions, Services 2) By Deployment: Web And Cloud Based, On-Premise 3) By End-User: Hospitals, Office-Based Physicians, Pharmaceuticals 

The ENT devices are used in the diagnosis and treatment of ear, nose, and throat diseases. The main types of ENT devices are hearing aid devices and equipment, hearing diagnostic devices and equipment, ENT surgical devices and equipment, hearing implants, voice prosthesis devices and equipment, and nasal splints. A hearing aid device is an electronic device that is worn in or behind the ear. It makes sounds louder so that a person with hearing loss can listen, communicate, and participate fully in daily activities. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The various end-users are hospitals and clinics, diagnostic laboratories, and others. The ENT devices market research report is one of a series of new reports from The Business Research Company that provides ENT devices market statistics, including ENT devices industry global market size, regional shares, competitors with an ENT devices market share, detailed ENT devices market segments, market trends and opportunities, and any further data you may need to thrive in the ENT devices industry. This ENT devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global ent devices market grew from $30.21 billion in 2022 to $32.98 billion in 2023 at a compound annual growth rate (CAGR) of 9.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The ent devices market is expected to grow to $45.04 billion in 2027 at a CAGR of 8.1%. Many governments across the world have introduced new healthcare acts and continuously increased healthcare spending. Healthcare coverage and expenditure also increased significantly. In 2021, the Indian government launched Ayushman Bharat PradhanMantri Jan ArogyaYojana (AB-PMJAY) is providing health assurance cover of up to ?5 Lakh per year per family for secondary and tertiary healthcare hospitalizations. Favourable government decisions and increased healthcare spending increased the demand for healthcare services and this drove the demand for ENT devices during this period. Interest rates globally are forecasted to rise in most of the developing and developed economies during the forecast period; this is expected to limit new investments in the market. Most countries across the world are raising interest rates to control inflation and also to limit the flow of capital out of the country. This is likely to affect new investments in terms of expansion, research, and development of new products. For instance, the US interest rates are expected to rise to 3.5% by 2021. These factors are expected to have a negative impact on the market as borrowing money becomes expensive, thereby affecting the market growth. ENT device manufacturers are investing in technologies to develop user-friendly and non-invasive equipment. They are continuously investing funds and resources into R&D to increase the scope of their devices. For instance, Intersect ENT developed Propel Mometasone Furoate Implant (PMFI) to treat chronic sinusitis. It is a bio-absorbable steroid that is placed directly into the sinus mucosa. It controls the release of drugs and dissolves over time. In another breakthrough in sinusitis treatment, SinuSys Corporation received FDA approval for its Vent-Os Sinus Dilation device. It is a small, low-pressure insert that is designed to gently open the sinus ostia and use the body’s natural mucosal fluids to expand the device. Major companies in the ENT devices market include Sonova Holdings AG, William Demant Holdings A/S, Medtronic Inc., GN Store Nord A/S, Cochlear Limited, Olympus Corporation, Stryker Corporation, Karl Storz SE & Co KG, Merck & Co, and Smith & Nephew plc. Asia-Pacific was the largest region in the global ENT devices market in 2022. North America was the second largest region in the global ENT devices market. Africa. was the smallest region in the global ENT devices market. The regions covered in the ENT devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the ENT devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The ENT devices market consists of sales of instruments such as Pure tone and impedance audiometers, BERA and OAE screening machines, nerve stimulators, and high-end microdrill that are used for diagnosis and treatment of ENT diseases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global ent devices market is segmented - 1) By Type: Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables

Wound care devices are used to prevent wound infections and promote wound healing. The main types of wound care devices are traditional adhesive dressings, negative-pressure wound therapy (NPWT), Traditional gauze dressings, and advanced wound care devices. Traditional wound dressing products including gauze, lint, plasters, bandages, and cotton wool are dry and used as primary or secondary dressings for protecting the wound from contaminations. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The various end-users are hospitals and clinics, diagnostic laboratories, and others. The wound care devices market research report is one of a series of new reports from The Business Research Company that provides wound care devices market statistics, including wound care devices industry global market size, regional shares, competitors with a wound care devices market share, detailed wound care devices market segments, market trends and opportunities, and any further data you may need to thrive in the wound care devices industry. This wound care devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global wound care devices market grew from $55.05 billion in 2022 to $59.79 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The wound care devices market is expected to grow to $80.02 billion in 2027 at a CAGR of 7.6%. Combination dressings are increasingly being used to treat chronic wounds. The most widely used combination dressing is an antimicrobial agent and a biological material that together acts as a combination dressing. Combination dressings blend the chemical and physical properties of two or more types of wound dressing products to provide, waterproofing, anti-bacterial and viral infections, and skin-friendly capabilities. For instance, ConvaTec offers AQUACEL combination dressings that are made up of Hydrofiber Technology that incorporates offers stitch bonding functionality and increases the tensile strength of the dressing to be used as a combination dressing with an absorbent for the treatment of chronic wounds. Most widely used combination dressings include silver alginate dressings, silver collagen dressings, collagen hydrochloride dressings, and foam dressings. These dressings are used in the treatment of chronic ulcers, traumatic wounds, and surgical wounds. Wound care device manufacturers should consider focusing on delivering wound care products such as hydrocolloid dressings to improve treatment effectiveness and usage. Hydrocolloid dressing consists of adhesives with gel-forming components composed of either silicone or polyurethane. They are waterproof and self–adhering advanced wound care products that provide a moisture-filled healing environment for the wound. Hydrocolloid bandages are utilized for burns with moderate severity, and granular wounds and protect healed skin by absorbing moisture and swells. For instance, BenQ, a consumer electronics company, offers hydrocolloid dressing which is waterproof, invisible, and against UV rays facilitating high moisture absorption and wound healing. Major companies in the wound care devices market include Medtronic Inc., 3M Company, Smith & Nephew plc, Cardinal Health, Inc., ConvaTec Group Plc, Henry Schein, Inc., Paul Hartmann AG, Essity AB, Coloplast, and Integra Lifesciences. Asia-Pacific was the largest region in the global wound care devices market in 2022. North America was the second largest region in the global wound care devices market. Africa. was the smallest region in the global wound care devices market. The regions covered in the wound care devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the wound care devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The wound care devices market consists of sales of instruments such as non-woven dressings, gauzes, hydrocolloids dressings, and others. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global wound care devices market is segmented - 1) By Type: Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables

Veterinary medical equipment refers to types of medical devices and surgical equipment such as endoscopic systems, dental equipment, and veterinary telemetry services that are used for operations, therapy, keeping track of diagnoses and vitals, and enhancing animal care to slow down the progression of diseases. The main types of veterinary medical equipment are veterinary diagnostic equipment, veterinary anaesthesia equipment, veterinary patient monitoring equipment, and other veterinary medical equipment that is used for animals such as small companion animals, large animals, and other animals. Veterinary anaesthesia equipment refers to the equipment that is used for animals to provide anesthesia. The products used are instruments, equipment, and disposables. These are used in veterinary hospitals, veterinary clinics, and research institutes. The veterinary medical equipment research report is one of a series of new reports from The Business Research Company that provides veterinary medical equipment statistics, including veterinary medical equipment industry global market size, regional shares, competitors with veterinary medical equipment shares, detailed veterinary medical equipment segments, market trends and opportunities, and any further data you may need to thrive in the veterinary medical equipment industry. This veterinary medical equipment research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global veterinary medical equipment market grew from $2.25 billion in 2022 to $2.42 billion in 2023 at a compound annual growth rate (CAGR) of 7.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, and affecting many markets across the globe. The veterinary medical equipment market is expected to grow from $3.15 billion in 2027 at a CAGR of 6.8%. The global economy is expected to go through a continued period of steady growth during the forecast period. The US economy showed steady growth during the historic period, and this is likely to continue during the forecast period. Emerging markets reached 4.8% in 2020 versus 3.6% in 2019. The continued economic growth is expected to contribute to increased standards of living of the global population and strengthen the presence of the middle class. Increased standards of living and a strengthened middle class will further drive the demand for improved nutrition, particularly animal protein, and increase focus on food quality and safety, supporting the growth of the animal medicine market in terms of feed additives. Thus, economic growth is expected to drive this market. The outbreak of COVID-19 disease (COVID-19) has acted as a massive restraint on the veterinary medical equipment market in 2020 as supply chains were disrupted due to trade restrictions and consumption declined due to lockdowns imposed by governments globally. COVID-19 is an infectious disease with flu-like symptoms including fever, cough, and difficulty breathing. The virus was first identified in 2019 in Wuhan, Hubei province of the People’s Republic of China, and has spread globally, including Western Europe, North America, and Asia. Steps by national governments to contain the transmission have resulted in a decline in economic activity with countries entering a state of "lock down" and the outbreak hurting businesses throughout 2020 and into 2021. However, it is expected that the veterinary medical equipment market will recover from the shock across the forecast period as it is a "black swan" event and not related to ongoing or fundamental weaknesses in the market or the global economy. Advances in diagnostic tools have improved veterinary services. Equipment such as portable x-ray and portable ultrasound scanners has increased the efficiency of veterinary treatment (especially in emergencies due to injury) for all equine/large animals, companions, exotic and mixed animal practices. For example, Wristscan V9, a diagnostic device, is being used for pregnancy tests for animals. In addition, the Alivecor iPhone app is used to perform electrocardiograms on animals for cardiologist review. Major companies in the veterinary medical equipment market include Carestream Health, IDEXX Laboratories Inc., Agfa Healthcare, MinXray Inc., and Diagnostic Imaging Systems. North America was the largest region in the veterinary medical equipment market in 2022. Asia-Pacific was the second-largest region in the veterinary medical equipment market. The regions covered in the veterinary medical equipment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the veterinary medical equipment market include Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The veterinary medical equipment market consists of sales of stethoscopes, ultrasounds, x-ray machines, sonography machines, and intravenous pumps. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global veterinary medical equipment market is segmented - 1) By Type: Veterinary Diagnostic Equipment, Veterinary Anesthesia Equipment, Veterinary Patient Monitoring Equipment, Other Veterinary Medical Equipment 2) By Product: Instruments/Equipment, Disposables 3) By Animal Type: Small Companion Animals, Large Animals, Other Animals 4) By End User: Veterinary Hospitals, Veterinary Clinics, Research Institutes

Dental equipment and supplies consist of tools, instruments, and supplies used by dentists, dental hygienists, and laboratories to provide dental treatment. The main types in the dental equipment and supplies are therapeutic dental equipment, general dental devices, and equipment, dental diagnostic imaging devices, and equipment, dental surgical devices, and equipment. Therapeutic dental equipment is used for the treatment of dental diseases. The type of expenditure used is public, private. The products used are instruments/equipment, disposables. The various end-users involved are hospitals and clinics, diagnostic laboratories, and others. The dental equipment and supplies market research report is one of a series of new reports from The Business Research Company that provides dental equipment and supplies market statistics, including dental equipment and supplies industry global market size, regional shares, competitors with a dental equipment and supplies market share, detailed dental equipment and supplies market segments, market trends and opportunities, and any further data you may need to thrive in the dental equipment and supplies industry. This dental equipment and supplies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global dental equipment and supplies market grew from $22.36 billion in 2022 to $24.99 billion in 2023 at a compound annual growth rate (CAGR) of 11.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The dental equipment and supplies market is expected to grow to $38.41 billion in 2027 at a CAGR of 11.3%. The dental industry is continuously incorporating advanced technologies for the manufacturing of dentures. Digital dentures deal with workflow involved in the fabrication of dentures which are prosthetic devices meant to replace missing teeth. This process utilizes software modules such as computer-aided design and computer-aided manufacturing (CAD/CAM) and materials to create precision-fitted dentures in short durations. The inclusion of this concept allows dental technicians to fabricate prostheses using material discs with quicker design time and better fit. Companies that offer digital dentures include AvaDent, DENTCA, Dentsply Sirona, Amann Girrbach. Major companies in the dental equipment and supplies market include Dentsply Sirona, Danaher, Carestream Health, 3M, Straumann. Asia-Pacific was the largest region in the global dental equipment and supplies market in 2022. Western Europe was the second-largest region in the global dental equipment and supplies market. Africa. was the smallest region in the global dental equipment and supplies market. The regions covered in the dental equipment and supplies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the dental equipment and supplies market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The dental equipment and supplies market consists of sales of dental radiology equipment, dental surgical navigation systems, CAD/CAM equipment, dental chairs, and other dental devices that are used for treatment of dental disorders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global dental equipment and supplies market is segmented - 1) By Type: Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables

The diagnostic devices (or) equipment market consists of sales of diagnostic equipment and related services by entities (organizations, sole traders, and partnerships) that are used to identify the nature or cause of a certain phenomenon, usually related to a medical condition. Some of the devices include magnetic resonance imaging apparatuses, temperature sensors or pacemakers. The main types of diagnostic devices or equipment are x-rayed systems, ultrasound systems, computed tomography (CT) scanners, magnetic resonance imaging systems, cardiovascular monitoring and diagnostic devices, and nuclear imaging devices. X-rays refer to a type of electromagnetic radiation, just like visible light. The mobility is stationary and mobile and is used in hospitals and diagnostic imaging centers. The global diagnostic equipment market size is expected to grow from $43.81 billion in 2021 to $47.74 billion in 2022 at a compound annual growth rate (CAGR) of 9.0%. The global diagnostic equipment market size is expected to grow to $59.46 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. An increase in the geriatric population is expected to propel the growth of the diagnostic devices market going forward. Older people are likely to suffer from diseases such as diabetes, cancer, and arthritis, among others, which would increase the demand for diagnostic devices. For instance, in 2020, according to the United Nations, a US-based intergovernmental organization, there are approximately 727 million persons are aged 65 years and above worldwide, and expected to reach approximately 1.5 billion persons by 2050. Therefore, the increase in the geriatric population is driving the growth of the diagnostic devices market.  The emergence of routine diagnostic kits is a key trend gaining popularity in the diagnostic devices market. Companies operating in the market are focusing on developing diagnostic kits to gain market coverage. For instance, in March 2022, Mylab Discovery Solutions, an India-based healthcare company, is set to launch an entire range of routine diagnostic kits and devices in conventional and point-of-care formats. Immunology, Biochemistry, and Haematology are the three main market sub-segments represented by the devices and kits included in them.  In July 2021, DiaSorin S.p.A., an Italy-based biotechnology company, acquired Luminex Corporation for a deal amount of $1.8 billion. Through the acquisition, DiaSorin would gain access to Luminex’s multiplexing technology and a portfolio that would strengthen its existing offering while expanding the group's presence in the United States. Further, this agreement would give the life science sector access to Luminex's applications, promoting academic and scientific research, improving collaboration with biopharma businesses, and boosting access to clinical multiplexing assays for upcoming Value-Based Care initiatives. Luminex Corporation is a US-based biotechnology company that manufactures medical diagnostic devices. Major players in the diagnostic equipment market include Philips Healthcare, Hitachi Medical Systems, Fujifilm Holdings, Siemens Healthcare, and GE Healthcare. The regions covered in global diagnostic equipment market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the diagnostic devices or equipment market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The global diagnostic equipment market is segmented - 1) By Type: X-Ray Systems, Ultrasound Systems, Computed Tomography (CT) Scanners, Magnetic Resonance Imaging Systems, Cardiovascular Monitoring and Diagnostic Devices, and Nuclear Imaging Device 2) By Mobility: Stationary, Mobile 3) By End User: Hospitals, Diagnostic imaging centres